Last reviewed · How we verify

NCT05928858

Clinical And Radiographic Evaluation Of Premixed Bio-ceramic Mineral Trioxide Aggregate Versus Calcium Hydroxide In Indirect Pulp Capping Of Young Permanent Molars: A Randomized Controlled Trial

Status unknown Phase 3 Last updated 28 July 2023
What this trial tests

Phase 3 trial testing Premixed Bio-ceramic MTA in Indirect Pulp Capping in 40 participants. Status unknown.

Timeline
1 September 2023
Primary endpoint
1 June 2024
1 September 2024

Quick facts

Lead sponsorCairo University
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date1 September 2023
Primary completion1 June 2024
Estimated completion1 September 2024

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 6 to 12, any sex, with Indirect Pulp Capping. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The present study aims to evaluate the clinical and radiographic success of premixed bio-ceramic MTA versus calcium hydroxide in indirect pulp capping of young permanent molars.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Indirect Pulp Capping

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05928858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing